FrieslandCampina Ingredients has received approval for its infant milk formula ingredient, Vivinal MFGM, in Thailand.
The milk fat globule membrane (MFGM) whey-derived ingredient can now be incorporated into both milk formulas and food products in the country.
The TFDA came to this decision through a three-year evaluation of the product, which has been found to support an infant's cognitive development.
About Vivinal MFGM
Vivinal MFGM is a cheese whey-derived protein concentrate, which FrieslandCampina Ingredients obtains through genle processing.
Through this procedure, the resulting product contains proteins, lipids, lactoferrin and immunoglobulin G, which can help support a baby's natural cognitive development.
An in vitro study has also found that Vivinal MFGM can exhibit an antiviral effect, highlighting the ingredient's potential to support a child's immune health.
Through this approval, FrieslandCampina Ingredients can now offer Vivinal MFGM in a wide range of infant food applications — allowing it to cater to the growing demand for functional ingredients within early-life formula products.
Notably, 74% of novel infant milk formulas released to the market contained at leaast on bioactive ingredient, suggesting that companies are acknowledging the need to go above and beyond when creating infant formulations.
Marketing Lead (APAC) – Early Life Nutrition at FrieslandCampina Ingredients, Sophie Nicolas, commented: “This achievement offers brands the opportunity to create premium infant milk formulas for the growing Thai market, with all the added health benefits this premium ingredient with bioactive proteins offers.”
“Families deserve access to the highest-quality infant milk formula when breastfeeding is not possible – and with this approval, we’re able to help brands provide more infants with the nutrients they need for a great start in life," she concluded.